James V. Cassella, SVP, Research & Development at Alexza Pharmaceuticals Inc. (ALXA), sold 46,222 shares at $0.34 ($16K) on 2012-06-06, disclosed to the SEC on 2012-06-08.
Scheduled sale ($16k) by SVP, Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CNCE | SELL | 2023-01-09 | $21K | — | Filing → |
| CNCE | SELL | 2022-02-16 | $12K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |